FundingWatcher
Home / Startups / Top biotech startups / Biotech startups that raised Series C / Biotech startups that raised Series C in San Francisco, United States

Biotech startups that raised Series C in San Francisco, United States

Updated 16 Nov 2026

Reset
Biotech startups that raised Series C in San Francisco, United States
One-time CSV
  • 26 funded companies, 24 with a website
  • Last round, amount, date, total raised and investors
  • CRM-ready CSV, 18 columns
  • Download right after payment
With founder contacts
Compiled to order
  • The full startup CSV, plus founders and executives
  • Up to 2 founders or CEOs per company, compiled to order
  • Name, job title and LinkedIn URL where found
  • Verified direct email per person
  • Startup CSV at once, contacts CSV by mail within 24 hours
Download right after paymentFree 10-row sampleSecure checkout by Stripe

Not sure about the data?

Download a free 10-row sample first. No account, no payment.

startups-biotech--series-c~san-francisco-california.csv26 rows × 18 columns
CompanyCityLast roundAmountDate
Chai DiscoverySan FranciscoSeries C$400.0M2026-07-14
Terremoto BiosciencesSan FranciscoSeries C$108.0M2026-04-15
LoyalSan FranciscoSeries C$100.0M2026-02-11
Culture BiosciencesSan FranciscoSeries C$80.0M2025-12-16
Frontier MedicinesSan FranciscoSeries C$20.0M2024-06-25
Asher BioSan FranciscoSeries C$55.0M2024-04-16
Unlearn.AISan FranciscoSeries C$50.0M2024-02-08
AizonSan FranciscoSeries C$20.0M2024-02-07

8 rows of the CSV in 5 of its 18 columns.

26
Startups
$3.7B
Total raised
6
Funded in the last 12 months
$897.0M
Raised in the last 12 months

Source: FundingWatcher. Data as of 16 November 2026. "Last 12 months" is the 365 days to that date.

Newest rounds

6 of 26
Company What they do Sector Last round Amount Date Total raised Investors Employees Founded
Chai Discovery Chai Discovery develops artificial intelligence models and software for protein engineering and molecular design. Artificial intelligence Series C $400.0M 2026-07-14 $631.0M Thrive Capital, OpenAI 11 to 50 2024
Terremoto Biosciences Terremoto Biosciences develops medicines using lysine-based covalent chemistry. Biotech Series C $108.0M 2026-04-15 $358.0M OrbiMed, Novo Holdings, Third Rock Ventures +2 51 to 100 2021
Loyal Loyal develops veterinary medicines to extend the healthy lifespan of senior dogs. Biotech Series C $100.0M 2026-02-11 $237.1M Khosla Ventures, First Round Capital, Quiet Capital +1 101 to 250 2019
Culture Biosciences Culture Biosciences provides automated systems for bioprocess development of biological products. Biotech Series C $80.0M 2025-12-16 $101.6M Y Combinator, National Science Foundation, BoxGroup +1 101 to 250 2016
Unlearn.AI Unlearn.AI uses AI, digital twins, and statistical methods to enable smaller, more efficient clinical trials. Artificial intelligence Series C $50.0M 2024-02-08 $134.8M Alumni Ventures, Insight Partners, 8VC +2 51 to 100 2017
Aizon Aizon provides a cloud-based SaaS platform that improves industrial processes in biotech and pharma. Artificial intelligence Series C $20.0M 2024-02-07 $44.8M 500 Global, FundersClub, Uncork Capital +2 101 to 250 2013

Table 1. Biotech startups that raised Series C in San Francisco, United States: the 6 newest rounds whose row carries a description, a city, a named fund and an amount. Source: FundingWatcher. Data as of 16 November 2026. Base: 26.

Largest rounds

Last 12 months
# Company What they do Sector Last round Amount Date Total raised Investors Employees Founded
1 Chai Discovery Chai Discovery develops artificial intelligence models and software for protein engineering and molecular design. Artificial intelligence Series C $400.0M 2026-07-14 $631.0M Thrive Capital, OpenAI 11 to 50 2024
2 Terremoto Biosciences Terremoto Biosciences develops medicines using lysine-based covalent chemistry. Biotech Series C $108.0M 2026-04-15 $358.0M OrbiMed, Novo Holdings, Third Rock Ventures +2 51 to 100 2021
3 Loyal Loyal develops veterinary medicines to extend the healthy lifespan of senior dogs. Biotech Series C $100.0M 2026-02-11 $237.1M Khosla Ventures, First Round Capital, Quiet Capital +1 101 to 250 2019
4 Culture Biosciences Culture Biosciences provides automated systems for bioprocess development of biological products. Biotech Series C $80.0M 2025-12-16 $101.6M Y Combinator, National Science Foundation, BoxGroup +1 101 to 250 2016

Table 2. Biotech startups that raised Series C in San Francisco, United States: the 4 largest rounds of the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.

Most active investors

By companies backed
#InvestorTypeLocation CompaniesShare Funded, 12 monthsLatest
1 Y Combinator Startup accelerator Mountain View, United States 5 19% 1 Culture Biosciences
2 Khosla Ventures Venture capital firm Menlo Park, United States 3 12% 1 Loyal
3 Alumni Ventures Angel group Manchester, United States 3 12%
4 RA Capital Management Startup incubator Boston, United States 2 8%
5 Felicis Venture capital firm Menlo Park, United States 2 8%
6 OpenAI San Francisco, United States 1 4% 1 Chai Discovery
7 Thrive Capital Startup incubator New York, United States 1 4% 1 Chai Discovery
8 Novo Holdings Corporate venture arm Hellerup, Denmark 1 4% 1 Terremoto Biosciences
9 Third Rock Ventures Venture capital firm Boston, United States 1 4% 1 Terremoto Biosciences
10 EcoR1 Capital Private equity firm San Francisco, United States 1 4% 1 Terremoto Biosciences
11 Cormorant Capital Venture capital firm New York, United States 1 4% 1 Terremoto Biosciences
12 OrbiMed Private equity firm New York, United States 1 4% 1 Terremoto Biosciences
13 First Round Capital Venture capital firm Philadelphia, United States 1 4% 1 Loyal
14 Collaborative Fund Venture capital firm New York, United States 1 4% 1 Loyal
15 Quiet Capital Venture capital firm San Francisco, United States 1 4% 1 Loyal

Table 3. Biotech startups that raised Series C in San Francisco, United States: the funds recorded as investors in the most companies. Latest: companies they back that raised in the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.

Sectors

SectorsCompaniesShareTotal raised
Health care 23 88% $3.2B
Software 8 31% $1.5B
Artificial intelligence 4 15% $944.7M
Hardware 4 15% $668.5M
Fintech 2 8% $140.0M

Table 4. Biotech startups that raised Series C in San Francisco, United States by sector. Source: FundingWatcher. Data as of 16 November 2026.

Funding stage

Funding stageCompaniesShareMedian last round
Series C 26 100% $55.0M

Table 5. Biotech startups that raised Series C in San Francisco, United States by stage of the most recent round. Source: FundingWatcher. Data as of 16 November 2026.

Rounds by month

Rounds by monthCompaniesShareRaised
July 2026 2 33% $409.0M
April 2026 1 17% $108.0M
February 2026 1 17% $100.0M
January 2026 1 17% $200.0M
December 2025 1 17% $80.0M

Table 6. Biotech startups that raised Series C in San Francisco, United States: most recent round by month, last 12 months. Source: FundingWatcher. Data as of 16 November 2026.

Most recent round by year

Most recent round by yearCompaniesShareRaised
2026 5 19% $817.0M
2025 2 8% $263.0M
2024 6 23% $145.0M
2022 1 4% $60.0M
2021 1 4% $220.0M
2020 1 4% $145.6M

Table 7. Biotech startups that raised Series C in San Francisco, United States by year of the most recent round. Source: FundingWatcher. Data as of 16 November 2026.

Founding year

Founding yearCompaniesShare
2023 or later 1 4%
2020 to 2022 2 8%
2015 to 2019 8 31%
2010 to 2014 8 31%
Before 2010 7 27%

Table 8. Biotech startups that raised Series C in San Francisco, United States by founding year. Source: FundingWatcher. Data as of 16 November 2026.

Team size

Team sizeCompaniesShare
11 to 50 11 42%
51 to 100 8 31%
101 to 250 6 23%
10,001 or more 1 4%

Table 9. Biotech startups that raised Series C in San Francisco, United States by headcount. Source: FundingWatcher. Data as of 16 November 2026.

Method

Sources, fields and exclusions of both files: Method.

Questions

How many biotech startups in San Francisco, United States whose last round is Series C are on the list?
26, in the file dated 16 November 2026. 6 of them closed their most recent round in the last 12 months.
What does the CSV contain?
One row per company, 18 columns: name, domain, website, linkedin, description, founded, employees, city, region, country, sectors, funding_stage, last_round, last_round_date, last_round_usd, total_raised_usd, rounds, investors.
How much does the list cost?
$29 one-time for all 26 rows, no account. Every investor and every startup, two files, cost $99. With founder contacts, up to 2 founders or CEOs per company compiled to order and mailed within 24 hours, $199.
What arrives after payment?
At once: the CSV download link, on the page after payment and by mail.
Can I see rows before buying?
The 3 rows under the buy button are rows of the CSV with every column. The form below it mails 10 rows.
How current is the data?
The file is dated 16 November 2026. The download link serves the current file each time it is opened.

Biotech startups that raised Series C in San Francisco, United States: 26 rows, CSV, $29 one-time.

At once: the CSV download link, on the page after payment and by mail.

Columns: name, domain, website, linkedin, description, founded, employees, city, region, country, sectors, funding_stage, last_round, last_round_date, last_round_usd, total_raised_usd, rounds, investors.

With founder contacts: $199 one-time. List CSV right after payment; up to 2 verified founder or CEO emails per company compiled to order within 24 hours.

Not sure about the data?

Download a free 10-row sample first. No account, no payment.

Biotech at other stages in San Francisco

Other sectors that raised Series C in San Francisco

Cite: FundingWatcher, 26 biotech companies in San Francisco, United States whose most recent round is Series C, 16 November 2026. https://fundingwatcher.com/startups/biotech/series-c/san-francisco-california/